Molbio Diagnostics Ltd
- ISIN
- INE869T01028
- Instrument key
- NSE_EQ|INE869T01028
as of 21/11/2026, 1:11:34 pm
- Open
- ₹1,549.80
- Day high
- ₹1,580.00
- Day low
- ₹1,483.10
- Prev. close
- ₹1,526.40
- Volume
- 7.01 L
- VWAP
- ₹1,530.99
02/Price history
Price chart
1 month · 30-minute candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.
- Change · 1M
- +15.35%1,296.10 → 1,495.00
- Period high
- ₹1,580.0020/11/2026
- Period low
- ₹1,228.5023/10/2026
- From high
- -5.38%+21.69% from low
- Avg volume
- 57.8K1.60 Cr total
- Candles
- 276121 up / 153 down
Candle data276 rows of open, high, low, close and volumeShowHide
| 20 Nov 2026 | 1,497.30 | 1,499.10 | 1,487.00 | 1,495.00 | -0.15% | 12.10 | 48.8K |
| 20 Nov 2026 | 1,514.70 | 1,515.40 | 1,483.10 | 1,497.60 | -1.13% | 32.30 | 57.9K |
| 20 Nov 2026 | 1,507.00 | 1,522.00 | 1,506.00 | 1,515.20 | +0.54% | 16.00 | 34.1K |
| 20 Nov 2026 | 1,509.00 | 1,510.00 | 1,505.00 | 1,506.90 | -0.14% | 5.00 | 11.1K |
| 20 Nov 2026 | 1,505.80 | 1,512.90 | 1,500.90 | 1,509.70 | +0.26% | 12.00 | 10.3K |
| 20 Nov 2026 | 1,502.50 | 1,507.40 | 1,500.60 | 1,505.90 | +0.23% | 6.80 | 11.3K |
| 20 Nov 2026 | 1,515.80 | 1,516.00 | 1,501.20 | 1,501.20 | -0.96% | 14.80 | 20.0K |
| 20 Nov 2026 | 1,516.10 | 1,516.40 | 1,507.70 | 1,515.60 | -0.03% | 8.70 | 8.6K |
| 20 Nov 2026 | 1,512.00 | 1,520.40 | 1,507.70 | 1,516.10 | +0.27% | 12.70 | 21.0K |
| 20 Nov 2026 | 1,524.50 | 1,529.80 | 1,510.30 | 1,512.20 | -0.81% | 19.50 | 33.2K |
Historical price and volume data · Showing 1–10 of 276
03/Valuation & returns
Key ratios vs sector
Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.
Price ÷ earnings per share
Worse than sector by 204%
Price ÷ book value per share
Worse than sector by 199%
Net income ÷ total assets
Worse than sector by 42%
Net income ÷ shareholders' equity
Worse than sector by 39%
EBIT ÷ capital employed
Worse than sector by 27%
Liquid assets ÷ current liabilities
Worse than sector by 38%
Enterprise value ÷ EBITDA
Worse than sector by 259%
04/Business
About the company
Sector: Healthcare
- ₹17,228 Cr
- $1.91B
reported in crore
reported in billion
Market capitalisation is reported at the sector-constituent level, not the standalone company level.
05/Profit & loss
Standalone income statement
Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.
- Revenue · Mar 2026
- ₹1,321 Cr+35.14% vs Mar 2025
- Net profit · Mar 2026
- ₹145 Cr+3.93% vs Mar 2025
- Operating margin
- 15.2%was 19.2%
- Revenue CAGR · 3p
- 31.6%profit 14.4% · op 14.9%
| Revenue | 1,321 | 978 | 763 |
|---|---|---|---|
| Revenue growthreported | 35.1% | 28.1% | — |
| Operating profit | 201 | 188 | 152 |
| Operating profit growthreported | 6.7% | 23.8% | — |
| Operating marginderived | 15.2% | 19.2% | 19.9% |
| Net profit | 145 | 140 | 111 |
| Net profit growthreported | 3.9% | 25.8% | — |
| Net marginderived | 11.0% | 14.3% | 14.6% |
| EPS — basic₹/share, annual | 12.83 | 12.40 | 9.86 |
Figures in ₹ crore. Margin rows are computed from the reported values.
Full annual line itemsRevenue, other income, expenses, tax, EPSShowHide
| Revenue | 1,313 | 971 | 756 | 327 |
|---|---|---|---|---|
| Other Income | 8 | 6 | 7 | 8 |
| Total Revenue | 1,321 | 978 | 763 | 335 |
| Total Expenses | 1,120 | 781 | 584 | 312 |
| Profit Before Tax | 198 | 188 | 152 | 23 |
| Tax | 53 | 48 | 41 | 7 |
| Profit After Tax | 145 | 140 | 111 | 16 |
| EPS - Basic | 12.83 | 12.40 | 9.86 | 6.91 |
| EPS - Diluted | 12.83 | 12.40 | 9.85 | 6.90 |
This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.
06/Balance sheet
Standalone balance sheet
Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.
- Total assets · Mar 2026
- ₹1,741 Cr+33.13% YoY
- Total liabilities
- ₹606 Cr
- Net worth
- ₹1,135 Cr
- Liabilities ÷ assets
- 34.8%lower means a lighter balance sheet
| Total assets | 1,741 | 1,307 | 1,077 | 920 |
|---|---|---|---|---|
| Total liabilities | 606 | 317 | 227 | 181 |
| Net worthderived | 1,135 | 990 | 850 | 739 |
| Liabilities ÷ assetsderived | 34.8% | 24.3% | 21.1% | 19.6% |
| Asset growthderived | 33.1% | 21.4% | 17.1% | — |
Figures in ₹ crore. Stacked chart height equals total assets.
Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
| Non-Current Assets | 737 | 481 | 354 | 309 |
|---|---|---|---|---|
| Current Assets | 1,004 | 827 | 724 | 611 |
| Total Assets | 1,741 | 1,307 | 1,077 | 920 |
| Current Liabilities | 382 | 304 | 210 | 178 |
| Net Current Asset | 622 | 523 | 514 | 433 |
| Non-Current Liabilities | 224 | 13 | 17 | 3 |
| Equity Capital | 1,135 | 990 | 850 | 739 |
| Total Equity & Liabilities | 1,741 | 1,307 | 1,077 | 920 |
Figures in ₹ crore unless the line item is per-share.
07/Cash flow
Standalone cash flow
Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.
- Operating · Mar 2026
- -₹38 Cr-115.28% YoY
- Investing
- -₹256 Cr
- Financing
- ₹292 Cr
- Free cash flow
- -₹294 Croperating + investing
| Operating activities | -38 | 249 | 38 | 68 |
|---|---|---|---|---|
| Operating changereported | -115.3% | 558.7% | -44.4% | — |
| Investing activities | -256 | -98 | -31 | -51 |
| Investing changereported | -161.8% | -211.4% | 38.4% | — |
| Financing activities | 292 | -17 | -24 | 31 |
| Financing changereported | 1785.2% | 28.3% | -178.2% | — |
| Net cash flowderived | -2 | 133 | -18 | 48 |
| Free cash flowoperating + investing | -294 | 151 | 6 | 17 |
Figures in ₹ crore.
Full annual line itemsProfit before tax through closing cash balanceShowHide
| Profit before tax | 198 | 188 | 152 | 23 |
|---|---|---|---|---|
| Income before WC changes | 276 | 247 | 238 | 42 |
| Change in Assets | -227 | -65 | -191 | 58 |
| Change in Liabilities | -34 | 131 | 34 | 0 |
| Change in WC | -261 | 66 | -157 | 58 |
| Cash flow from Operations | -38 | 249 | 38 | 68 |
| Cash flow from Investing | -256 | -98 | -31 | -51 |
| Cash flow from Financing | 292 | -17 | -24 | 31 |
| Total Cash Flow | -2 | 133 | -18 | 48 |
| Cash (Start of the year) | 111 | -23 | -5 | -52 |
| Cash (End of the year) | 109 | 111 | -23 | -5 |
Figures in ₹ crore unless the line item is per-share.
09/Events
Corporate actions
Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.
No corporate actions on record
10/Comparison
Peers & competitors
Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.
| APOLLOHOSPApollo Hospitals Enter. L | Healthcare Services | ₹9,200.00 | +5.29% | 14.13 L | ₹1,32,139 Cr | $14.68B | |
| MAXHEALTHMAX Healthcare INS Ltd | Healthcare Services | ₹1,081.00 | +3.88% | 95.32 L | ₹1,05,080 Cr | $11.68B | |
| MANIPALHOSManipal Health Enterpri L | Healthcare | ₹702.20 | +0.83% | 11.62 L | ₹92,366 Cr | $10.26B | |
| ASTERDMAster DM Quality Care Ltd | Healthcare Services | ₹779.30 | +5.41% | 26.66 L | ₹67,960 Cr | $7.55B | |
| FORTISFortis Healthcare Ltd | Healthcare Services | ₹825.00 | +1.87% | 22.88 L | ₹62,284 Cr | $6.92B | |
| MEDANTAGlobal Health Limited | Healthcare Services | ₹1,480.20 | +0.13% | 2.65 L | ₹39,829 Cr | $4.43B | |
| NHNarayana Hrudayalaya Ltd. | Healthcare Services | ₹1,945.00 | +3.84% | 7.85 L | ₹39,757 Cr | $4.42B | |
| LALPATHLABDR. LAL Path Labs Ltd. | Healthcare Services | ₹1,989.00 | +1.31% | 2.65 L | ₹33,680 Cr | $3.74B | |
| KIMSKrishna Inst Of MED SCI L | Healthcare Services | ₹795.60 | +3.62% | 10.44 L | ₹33,483 Cr | $3.72B | |
| SYNGENESyngene International Ltd | Diversified | ₹451.70 | +3.28% | 25.58 L | ₹18,240 Cr | $2.03B |
Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10
11/Coverage
Company news
Articles published in the last seven days, paginated by the provider.
No news in the last seven days
Company news is available for a rolling one-week window.